USA Core CPI (MoM) for Aug 0.600% vs 0.300% Est; Prior 0.300%
USA Core CPI (MoM) for Aug 0.600% vs 0.300% consensus estimate. The prior reading was 0.300%.
Seelos Therapeutics Announces Participation Of Acadia Healthcare In The Registration Directed Study Of SLS-002 (Intranasal Racemic Ketamine) For Acute Suicidal Ideation And Behavior In Patients With Major Depressive Disorder
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,
Eastman Sees Q3 Adj. EPS $2.00
Eastman Chemical Company (NYSE: EMN) provided an update on its third-quarter 2022 financial results.
Guardforce AI Announces LOI To Acquire Shenzhen Kewei Robot Technology Company Limited
Acquisition will Provide New Robotics-as-a-Service Capabilities, Add Key Patents
and Expand Global Fortune 500 Customer Base
Agreement Supersedes Previously Announced LOI to Acquire 19 Robotics Subsidiaries of Shenzhen
Graphex Technologies Enters MOU With ReCharge Global To Develop Graphite Manufacturing Facilities For Mine-to-Battery Graphite Supply To EV Industry
ROYAL OAK, Mich., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Graphex Technologies, LLC, a wholly owned subsidiary of Graphex Group Limited (collectively "Graphex") (NYSE:GRFX, HKSE: 6128)))) and a global
Ingersoll Rand To Acquire Pedro Gil
Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, has entered into an agreement to acquire Pedro Gil Construcciones Mecánicas, S.L. ("Pedro
Crestwood Announces Secondary Offering Of 11.4M Common Units And Concurrent Common Unit Repurchase Of Up To $125M Of Common Units
Crestwood Equity Partners LP (NYSE:CEQP) ("Crestwood") today announced that certain subsidiaries of Chord Energy Corporation (NASDAQ:CHRD) (f/k/a Oasis Petroleum Inc.) (the "Selling Unitholders")
Cheniere Raises FY22 DCF Guidance To $8.1B-$8.6B
Cheniere is also raising full year 2022 Consolidated Adjusted EBITDA2 guidance to $11.0 - $11.5 billion and full year 2022 DCF2 guidance to $8.1 - $8.6
Polyrizon Submites Patent Application For Its Platform Technologies
Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and